Penn State Health Milton S. Hershey Medical Center Joins Global Clinical Trial Evaluating Antiviral Drug Remdesivir for Treatment of COVID-19

Study enrolls first patients in COVID-19 clinical trial using a drug previously developed to treat Ebola HERSHEY, Pa. –Penn State Health Milton S. Hershey Medical Center has begun enrolling participants in an international clinical trial evaluating an investigational antiviral drug, remdesivir, for treatment of coronavirus disease 2019 (COVID-19). Remdesivir has been previously tested in humans with Ebola … Continue reading Penn State Health Milton S. Hershey Medical Center Joins Global Clinical Trial Evaluating Antiviral Drug Remdesivir for Treatment of COVID-19